De Serres, "Efficacy of alpha-1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema," Orphanet Journal of Rare Diseases, vol.
Salinas Medina et al., "In vitro evaluation of a novel mRNA-based therapeutic strategy for the treatment of patients suffering from alpha-1-antitrypsin deficiency," Nucleic Acid Therapeutics, vol.
Worldwide racial and ethnic distribution of alpha-1-antitrypsin deficiency: details of an analysis of published genetic epidemiological surveys.
Alpha-1-antitrypsin deficiency: smoking, decline in lung function and implications for therapeutic trials.
The PAS stain with and without diastase demonstrated intracytoplasmic granules, which is nonspecific but raised the possibility of alpha-1-antitrypsin
is an endogenous inhibitor of proinflammatory cytokine production in whole blood.
Worldwide racial and ethnic distribution of alpha-1-antitrypsin
deficiency: summary of an analysis of published genetic epidemiologic surveys.
Diagnosis of alpha-1-antitrypsin
deficiency: an algorithm of quantification, genotyping, and phenotyping.
deficiency: biochemistry and clinical manifestations [Review].
Amino acid substitution Glu-Lys in alpha-1-antitrypsin
Evaluation of an integrative diagnostic algorithm for the identification of people at risk for alpha-1-antitrypsin
Characterization of the intracellular mechanism causing the alpha-1-antitrypsin
[Null.sub.granite falls] deficiency state.